Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to Date

Sheng IY, Ornstein MC

Cancer Management and Research 2020, 12:4871-4881

Published Date: 23 June 2020